Artwork

Content provided by The Immune-Mediated Inflammatory Disease Forum. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Immune-Mediated Inflammatory Disease Forum or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

28:33
 
Share
 

Manage episode 416023082 series 1044916
Content provided by The Immune-Mediated Inflammatory Disease Forum. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Immune-Mediated Inflammatory Disease Forum or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the improvement of PROs reported in a Phase 2 trial with deucravacitinib.
  continue reading

360 episodes

Artwork
iconShare
 
Manage episode 416023082 series 1044916
Content provided by The Immune-Mediated Inflammatory Disease Forum. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Immune-Mediated Inflammatory Disease Forum or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the improvement of PROs reported in a Phase 2 trial with deucravacitinib.
  continue reading

360 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play